EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Regulatory framework for fast track approval of Drugs in different countries

Vasavi Pachika, MANYA RaJ Gilla, Vijaya Sindhuri Gopu

International Journal of Drug Regulatory Affairs · 15.06.2025 · 13 (2) · 7-16

DOI: 10.22270/ijdra.v13i2.751 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Regulatory Affairs, online erschienen am 15.06.2025. Verfasst von Vasavi Pachika und 2 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This review aims to analyze and compare the regulatory frameworks for fast-track drug approval in various countries, focusing on the US, Europe, Japan, and Australia. The study highlights the significance of expedited drug approval pathways in addressing unmet medical needs while ensuring safety and efficacy. A detailed evaluation of the standard approval pathways is performed to provide context, followed by a comparative analysis of fast-track mechanisms. Challenges associated with these programs are also explored. The study identifies similarities & differences in expedited drug approval pathways across countries, highlighting unique features of the Fast Track Designation in the U.S., PRIME in Europe, Sakigake in Japan, and Priority Review in Australia. Despite their effectiveness in accelerating drug availability, challenges such as balancing speed with rigorous evaluation, regulatory inconsistencies, and resource allocation are evident. Expedited approval programs significantly impact public health by improving access to innovative therapies. However, harmonizing regulatory processes and addressing associated challenges are crucial for optimizing their implementation globally.

Zitieren

APA

Pachika, V., Gilla, M. R., & Gopu, V. S. (2025). Regulatory framework for fast track approval of Drugs in different countries. International Journal of Drug Regulatory Affairs, 13(2), 7-16. https://doi.org/10.22270/ijdra.v13i2.751

Vancouver

Pachika V, Gilla MR, Gopu VS. Regulatory framework for fast track approval of Drugs in different countries. International Journal of Drug Regulatory Affairs. 2025;13(2):7-16. doi:10.22270/ijdra.v13i2.751

BibTeX
@article{Pachika2025,
  author = {Pachika, Vasavi and Gilla, MANYA RaJ and Gopu, Vijaya Sindhuri},
  title = {Regulatory framework for fast track approval of Drugs in different countries},
  journal = {International Journal of Drug Regulatory Affairs},
  year = {2025},
  volume = {13},
  number = {2},
  pages = {7--16},
  doi = {10.22270/ijdra.v13i2.751}
}
Kostenlos starten →